Physician profile
Sean Patrick Cleary
NPI 1134665003
$106,880.88
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $29K · 2021: $15K · 2022: $16K · 2023: $1,627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $127.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $69,970.31 | 2019-2022 | |
| Olympus America INC. | $10,265.87 | 2019-2020 | |
| Olympus Corporation | $9,546.20 | 2019-2020 | |
| Astrazeneca Uk Limited | $8,972.00 | 2022-2023 | Imfinzi |
| Ethicon INC. | $4,637.50 | 2020-2022 | |
| Sirtex Medical INC | $1,750.00 | 2019 | |
| Erbe Elektromedizin Gmbh | $940.20 | 2020 | |
| Intuitive Surgical, INC. | $329.77 | 2020-2022 | |
| Olympus Winter & Ibe Gmbh | $171.60 | 2019 | |
| Stryker Corporation | $170.16 | 2022 | |
| Taiho Oncology, INC. | $127.27 | 2023 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Cleary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.